RheaVita provides continuous freeze-drying technology for (bio)pharmaceutical products. Resolving the issues and shortcomings related to traditional batch freeze-drying, but also providing new opportunities. The technology integrates all freeze-drying process step unit operations in a continuous production line. Process with the constant infeed of products and the concomitant outfeed of the dried product.The manufacturing approach avoids scale-up issues and reduces cycle times. It allows fast product development and reduces time-to-market.

It lowers production costs, makes use of smaller manufacturing installations, requires less clean room space, provides improved quality assurance with 100% inspection with inherent potential for real-time-release and leads to improved and uniform product quality and process uniformity.RheaVita strives to develop and market fundamental improvements for the manufacturing of pharmaceutical medicines. This is done through technological developments based upon thorough fundamental research.